JWH 018 DRUG OPTIONS

induces dose-dependent toxicological modifications in these brain regions [216]. There are actually changes in grey or white issue density in several areas of your brain such as the frontal and parietal lobes [217] and degenerative modifications during the hippocampus and amygdala are documented much more typically [218]. These findings advise that